Evidence map›Paper›PMID 40621219›Full record

ArticleJournal of arrhythmia2025

AI-ECG for early detection of atrial fibrillation: First-year results from a stroke prevention study in Shimizu, Japan.

Mayumi Masumura, Atsuyuki Ohno, Haruhiko Yoshinaga, Takeshi Sasaki, Yasuteru Yamauchi, Hitoshi Hachiya, Atsushi Takahashi, Yasushi Imai, Hideo Fujita, Kensuke Ihara and 4 more

Abstract read
In one paragraph

Article in Journal of arrhythmia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mayumi MasumuraDepartment of Cardiology Shizuoka City Shimizu Hospital Shizuoka Japan.ORCID https://orcid.org/0009-0009-0171-544X
Atsuyuki OhnoDepartment of Cardiology Shizuoka City Shimizu Hospital Shizuoka Japan.
Haruhiko YoshinagaShizuoka City Shimizu Medical Association Shizuoka Japan.
Takeshi SasakiDepartment of Cardiology NHO Disaster Medical Center Tokyo Japan.
Yasuteru YamauchiDepartment of Cardiology Japan Red Cross Yokohama City Bay Hospital Yokohama Kanagawa Japan.ORCID https://orcid.org/0000-0002-4661-2999
Hitoshi HachiyaCardiovascular Center Tsuchiura Kyodo Hospital Ibaraki Japan.
Atsushi TakahashiDepartment of Cardiology Yokosuka Kyosai Hospital Yokosuka Kanagawa Japan.
Yasushi ImaiDivision of Clinical Pharmacology and Division of Cardiovascular Medicine Jichi Medical University Shimotsuke Japan.
Hideo FujitaDepartment of Cardiovascular Medicine Jichi Medical University Saitama Medical Center Saitama Japan.
Kensuke IharaDepartment of Cardiovascular Medicine Institute of Science Tokyo Tokyo Japan.
Yusuke EbanaDepartment of Medical Genetics Institute of Science Tokyo Tokyo Japan.ORCID https://orcid.org/0000-0002-5162-0838
Toshihiro TanakaDepartment of Human Genetics and Disease Diversity Institute of Science Tokyo Tokyo Japan.
Tetsushi FurukawaInstitute of Science Tokyo Tokyo Japan.
Tetsuo SasanoDepartment of Cardiovascular Medicine Institute of Science Tokyo Tokyo Japan.ORCID https://orcid.org/0000-0003-3582-6104

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: An artificial intelligence algorithm-guided electrocardiogram (AI-ECG) has been developed to detect atrial fibrillation (AF) in patients with sinus rhythm (SR). However, its utility for population-based screening remains unclear in Japan. Method and Results: In this prospective cohort study, "SPAFS" (Stroke Prevention by Early Detection of AF in Shimizu), participants who underwent health examinations at the Shimizu Medical Association Examination Center from January 2022 to July 2023 were enrolled, with known AF excluded. ECGs were categorized by AI as low-, moderate-, or high risk: non-SR were labeled as non-applicable (NA). All participants underwent 7-day single-lead ECG monitoring. Among 362 participants (61.1 ± 10.5 years, 38% male, CHADS2 score 0.49 ± 0.70), AF was newly detected in 3.0% ( Conclusions: AI-ECG risk determination correlated with AF detection in a Japanese healthy cohort, especially in the aged population, supporting its utility as a population-based screening tool.

Indexed as

artificial intelligenceatrial fibrillationcohort studyelectrocardiogramscreening

Identifiers

PMID40621219
PMCPMC12227326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.